Distinct features of the portalhypertensive syndrome in patients with advanced chronic liver disease due to non-alcoholic steatohepatitis
Rafael Paternostro(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Wilhelmus J. Kwanten(Antwerp University Hospital), Benedikt Simbrunner(Austrian Academy of Sciences), Thomas Vanwolleghem(Erasmus MC), Bernhard Scheiner(Medical University of Vienna), Georg Semmler(University of Southern Denmark), Sven Francque(Inova Health System), Jeannette Becker(Friedrich-Alexander-Universität Erlangen-Nürnberg), Ernst Eigenbauer(Medical University of Vienna), Theresa Bucsics(Medical University of Vienna), Benedikt Hofer(Austrian Academy of Sciences), Michael Trauner(Medical University of Vienna), Luisa Vonghia(Antwerp University Hospital), Helena Schiffke(Medical University of Vienna), David JM Bauer(Brigham and Women's Hospital), Philipp Schwabl(Austrian Academy of Sciences), Mattias Mandorfer(Medical University of Vienna), Ali Bagdadi(Antwerp University Hospital), Vera Panagl(Medical University of Vienna)
Cited by 1
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k